logo
Select company
Select metric
-184.91%EBITDA Margin
VS
Market
10
Sector
33
Industry
20
History
87
$ 6.32Close
$ 5.03 - $ 85.23 52-Week Range
Ticker Information

Ticker

NAOV

Company Name

NANOVIBRONIX INC

Sector

Healthcare

Industry

Medical Devices

Exchange

NASDAQ

NANOVIBRONIX INC - EBITDA Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NAOV - EBITDA % Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA MarginRevenues
6/30/2025$ -4.33M-184.91%$ 2.34M
3/31/2025$ -5.41M-203.31%$ 2.66M
12/31/2024$ -3.58M-139.99%$ 2.56M
9/30/2024$ -2.91M-88.51%$ 3.29M
6/30/2024$ -2.61M-77.47%$ 3.37M
3/31/2024$ -2.95M-103.47%$ 2.85M
12/31/2023$ -3.44M-150.46%$ 2.28M
9/30/2023$ -4.44M-442.33%$ 1M
6/30/2023$ -4.69M-730.02%$ 643K
3/31/2023$ -4.97M-596.04%$ 834K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NANOVIBRONIX INC's latest trailing twelve months (TTM) EBITDA % stands at -712.1%.
  • Over the past 5 years, NANOVIBRONIX INC's average EBITDA % has been -535.61%.
  • The median EBITDA % for NANOVIBRONIX INC during this period was -562.45%
  • NANOVIBRONIX INC reached its highest EBITDA % over the past 5 years at -77.47%.
  • The lowest EBITDA % recorded by NANOVIBRONIX INC in the same timeframe -1330.56%

NANOVIBRONIX INC's EBITDA % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA % Benchmarks
CompanyEBITDA %
XBIO : XENETIC BIOSCIENCES INC -126.03%VTAK : CATHETER PRECISION INC -2519.17%MOVE : MOVANO INC -4239.36%TIVC : TIVIC HEALTH SYSTEMS INC -1312.77%BBLG : BONE BIOLOGICS CORP -SINT : SINTX TECHNOLOGIES INC -623%ONCO : ONCONETIX INC -3296.76%SPRB : SPRUCE BIOSCIENCES INC -3526.87%BNBX : APPLIED DNA SCIENCES INC -389.78%WORX : SCWORX CORP -44.11%

Definition of EBITDA Margin

[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
EBITDA / Revenues
(=) EBITDA %
EBITDA % for NANOVIBRONIX INC is calculated as follows: EBITDA [ $ -4.42M ] / Revenues [ $ 620K ]
(=) EBITDA % [ -712.1% ]

NAOV - EBITDA Margin, Last 5 years

-1330.56%

Minimum

Mar 31, 2021

-77.47%

Maximum

Jun 30, 2024

-535.61%

Average

-562.45%

Median

EBITDA % Benchmark Analysis

The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.2% with a standard deviation of 26.73%.
The following table provides additional summary stats:
EBITDA % in the Market:
filtered constituents3.29K
min-74.33%
max97.24%
average16.2%
median14.74%
std26.73%